Literature DB >> 24133568

Letter to the editor: Temporary renal insufficiency associated with topical tacrolimus treatment of multilocal pyoderma gangrenosum.

Uwe Wollina1.   

Abstract

Entities:  

Year:  2013        PMID： 24133568      PMCID： PMC3797021          DOI： 10.3315/jdcr.2013.1154

Source DB:  PubMed          Journal:  J Dermatol Case Rep        ISSN： 1898-7249


× No keyword cloud information.
  7 in total

Review 1.  Deciphering calcineurin inhibitor nephrotoxicity: a pharmacological approach.

Authors:  Nicolas Pallet; Christophe Legendre
Journal:  Pharmacogenomics       Date:  2010-10       Impact factor: 2.533

2.  Successful treatment of pyoderma gangrenosum associated with juvenile idiopathic arthritis with a combination of topical tacrolimus and oral prednisolone.

Authors:  Pradeep Kumar Shenoy Chandrasekhara; Nambiar Veettil Jayachandran; Joe Thomas; Sumeet Agrawal; Gumdal Narsimulu
Journal:  Clin Rheumatol       Date:  2009-02-03       Impact factor: 2.980

3.  Effect of steroid-free low concentration calcineurin inhibitor maintenance immunosuppression regimen on renal allograft histopathology and function.

Authors:  Neha Nainani; Nilang Patel; Nauman Tahir; Rakesh Kumar; Edit Weber-Shrikant; Aijaz A Gundroo; Brian M Murray; Kathleen M Tornatore; George A Blessios; Rocco C Venuto
Journal:  Nephrol Dial Transplant       Date:  2011-11-05       Impact factor: 5.992

Review 4.  Topical calcineurin inhibitors in the treatment of atopic dermatitis - an update on safety issues.

Authors:  Magdalena Czarnecka-Operacz; Dorota Jenerowicz
Journal:  J Dtsch Dermatol Ges       Date:  2011-10-06       Impact factor: 5.584

5.  Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity.

Authors:  Christoph Metalidis; Evelyne Lerut; Maarten Naesens; Dirk R J Kuypers
Journal:  Transplantation       Date:  2011-05-27       Impact factor: 4.939

6.  Characterization of a phase 1 metabolite of mycophenolic acid produced by CYP3A4/5.

Authors:  Nicolas Picard; Thierry Cresteil; Aurélie Prémaud; Pierre Marquet
Journal:  Ther Drug Monit       Date:  2004-12       Impact factor: 3.681

Review 7.  [Differential therapeutic aspects of analgesia with oral sustained-release strong opioids: application intervals, metabolism and immunosuppression].

Authors:  K Güttler; R Sabatowski
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107
  7 in total
  2 in total

Review 1.  Pyoderma gangrenosum: pathogenetic oriented treatment approaches.

Authors:  Uwe Wollina; Georgi Tchernev
Journal:  Wien Med Wochenschr       Date:  2014-06-05

Review 2.  Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.

Authors:  Carlo Alberto Maronese; Matthew A Pimentel; May M Li; Alex G Ortega-Loayza; Angelo Valerio Marzano; Giovanni Genovese
Journal:  Am J Clin Dermatol       Date:  2022-05-24       Impact factor: 6.233
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.